The kit receptor and its ligand, steel factor, as regulators of hemopoiesis.

IF 3.5 Q1 DENTISTRY, ORAL SURGERY & MEDICINE Cancer cells (Cold Spring Harbor, N.Y. : 1989) Pub Date : 1991-12-01
H E Broxmeyer, R Maze, K Miyazawa, C Carow, P C Hendrie, S Cooper, G Hangoc, S Vadhan-Raj, L Lu
{"title":"The kit receptor and its ligand, steel factor, as regulators of hemopoiesis.","authors":"H E Broxmeyer,&nbsp;R Maze,&nbsp;K Miyazawa,&nbsp;C Carow,&nbsp;P C Hendrie,&nbsp;S Cooper,&nbsp;G Hangoc,&nbsp;S Vadhan-Raj,&nbsp;L Lu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Mouse strains carrying mutations at the Dominant White Spotting (W) locus or the Steel (Sl) locus are anemic and display defects in pigmentation and gametogenesis. In W mutants the anemia is due to a deficiency of hemopoietic stem cells and, in Sl mutants, to a deficiency of supporting stromal cells in the bone marrow. The W locus encodes the c-kit proto-oncogene product, a cell surface receptor with protein-tyrosine kinase activity, and the Sl locus encodes its ligand, a hemopoietic cytokine known variously as Steel factor (SLF), mast cell growth factor, stem cell factor, and Kit ligand. SLF can synergize with a number of other cytokines to stimulate growth of hemopoietic progenitors in vitro and stimulates blood cell production in vivo in animals. Here we review the biological activities of SLF, with particular emphasis on its effects on hemopoietic stem and progenitor cells. We also discuss present knowledge of the molecules involved in SLF-triggered signal transduction, and speculate on potential therapeutic applications for SLF in human disease.</p>","PeriodicalId":77504,"journal":{"name":"Cancer cells (Cold Spring Harbor, N.Y. : 1989)","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"1991-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer cells (Cold Spring Harbor, N.Y. : 1989)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Mouse strains carrying mutations at the Dominant White Spotting (W) locus or the Steel (Sl) locus are anemic and display defects in pigmentation and gametogenesis. In W mutants the anemia is due to a deficiency of hemopoietic stem cells and, in Sl mutants, to a deficiency of supporting stromal cells in the bone marrow. The W locus encodes the c-kit proto-oncogene product, a cell surface receptor with protein-tyrosine kinase activity, and the Sl locus encodes its ligand, a hemopoietic cytokine known variously as Steel factor (SLF), mast cell growth factor, stem cell factor, and Kit ligand. SLF can synergize with a number of other cytokines to stimulate growth of hemopoietic progenitors in vitro and stimulates blood cell production in vivo in animals. Here we review the biological activities of SLF, with particular emphasis on its effects on hemopoietic stem and progenitor cells. We also discuss present knowledge of the molecules involved in SLF-triggered signal transduction, and speculate on potential therapeutic applications for SLF in human disease.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
kit受体及其配体钢铁因子作为造血调节因子。
携带显性白色斑点位点(W)或显性钢位点(Sl)突变的小鼠品系贫血,在色素沉着和配子发生方面表现出缺陷。在W突变体中,贫血是由于造血干细胞的缺乏,而在Sl突变体中,是由于骨髓中支持基质细胞的缺乏。W位点编码c-kit原癌基因产物,一种具有蛋白酪氨酸激酶活性的细胞表面受体,Sl位点编码其配体,一种造血细胞因子,被称为钢铁因子(SLF)、肥大细胞生长因子、干细胞因子和Kit配体。SLF能与多种细胞因子协同作用,在体外刺激造血祖细胞生长,在体内刺激动物血细胞生成。本文综述了SLF的生物学活性,重点介绍了其对造血干细胞和祖细胞的作用。我们还讨论了参与SLF触发信号转导的分子的现有知识,并推测SLF在人类疾病中的潜在治疗应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Hormonal Carcinogenesis Receptor-mediated mitogenic signals and lung cancer. Alpha-amidation of peptide hormones in lung cancer. The kit receptor and its ligand, steel factor, as regulators of hemopoiesis. New directions in cancer therapy based on aberrant expression of glycosphingolipids: anti-adhesion and ortho-signaling therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1